Erik De Clercq
Rega Institute for Medical Research
K.U.Leuven
Minderbroedersstraat 10
B-3000 Leuven
Belgium
Name/email consistency: high
- The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures. De Clercq, E. Med. Res. Rev (2011)
- Interferon and its inducers--a never-ending story: "old" and "new" data in a new perspective. De Clercq, E. J. Infect. Dis. (2006)
- (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU). De Clercq, E. Med. Res. Rev (2005)
- New approaches toward anti-HIV chemotherapy. De Clercq, E. J. Med. Chem. (2005)
- Antiviral drug discovery and development: where chemistry meets with biomedicine. De Clercq, E. Antiviral Res. (2005)
- Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines. De Clercq, E., Andrei, G., Balzarini, J., Leyssen, P., Naesens, L., Neyts, J., Pannecouque, C., Snoeck, R., Ying, C., Hocková, D., Holý, A. Nucleosides. Nucleotides. Nucleic. Acids (2005)
- Acyclic nucleoside phosphonates: a key class of antiviral drugs. De Clercq, E., Holý, A. Nat. Rev. Drug. Discov (2005)
- Nucleoside analogues exerting antiviral activity through a non-nucleoside mechanism. De Clercq, E. Nucleosides. Nucleotides. Nucleic. Acids (2004)
- Antiviral drugs in current clinical use. De Clercq, E. J. Clin. Virol. (2004)
- HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches. De Clercq, E. Int. J. Biochem. Cell Biol. (2004)
- Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections. De Clercq, E., Neyts, J. Rev. Med. Virol. (2004)
- Antivirals and antiviral strategies. De Clercq, E. Nat. Rev. Microbiol. (2004)
- Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster. De Clercq, E. Biochem. Pharmacol. (2004)
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present, and future. De Clercq, E. Chem. Biodivers. (2004)
- Highly potent and selective inhibition of varicella-zoster virus replication by bicyclic furo[2,3-d]pyrimidine nucleoside analogues. De Clercq, E. Med. Res. Rev (2003)
- The bicyclam AMD3100 story. De Clercq, E. Nat. Rev. Drug. Discov (2003)
- Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. De Clercq, E. Clin. Microbiol. Rev. (2003)
- Cidofovir in the treatment of poxvirus infections. De Clercq, E. Antiviral Res. (2002)
- Strategies in the design of antiviral drugs. De Clercq, E. Nat. Rev. Drug. Discov (2002)
- New anti-HIV agents and targets. De Clercq, E. Med. Res. Rev (2002)
- Highlights in the development of new antiviral agents. De Clercq, E. Mini. Rev. Med. Chem (2002)
- 2001 ASPET Otto Krayer Award Lecture. Molecular targets for antiviral agents. De Clercq, E. J. Pharmacol. Exp. Ther. (2001)
- Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections. De Clercq, E. Clin. Microbiol. Rev. (2001)
- New developments in anti-HIV chemotherapy. De Clercq, E. Farmaco (2001)
- Antiviral drugs: current state of the art. De Clercq, E. J. Clin. Virol. (2001)
- New developments in anti-HIV chemotherapy. De Clercq, E. Curr. Med. Chem. (2001)
- Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists. De Clercq, E., Schols, D. Antivir. Chem. Chemother. (2001)
- Hamao Umezawa Memorial Award Lecture: "An Odyssey in the Viral Chemotherapy Field". De Clercq, E. Int. J. Antimicrob. Agents (2001)
- Inhibition of HIV infection by bicyclams, highly potent and specific CXCR4 antagonists. De Clercq, E. Mol. Pharmacol. (2000)
- Perspectives for the treatment of hepatitis B virus infections. De Clercq, E. Int. J. Antimicrob. Agents (1999)
- The emerging role of fusion inhibitors in HIV infection. De Clercq, E. Drugs. R. D (1999)
- Carbocyclic adenosine analogues as S-adenosylhomocysteine hydrolase inhibitors and antiviral agents: recent advances. De Clercq, E. Nucleosides. Nucleotides (1998)
